(Aug 31, 2009) Indian pharmaceutical company Aurobindo Pharma has received the FDA's final approval for clindamycin hydrochloride capsules USP 150mg and 300mg. Clindamycin hydrochloride capsules USP 150mg and 300mg are generic equivalent to Cleocin Hydrochloride Capsules 150mg and 300mg of Pharmacia & Upjohn Company.
According to Aurobindo Pharma, clindamycin hydrochloride is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria and falls under the anti-infective therapeutic segment. The product will be launched shortly.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment